ATE279395T1 - Carbostyrylderivate zur inhibition von hautrötungen und/oder von hautpigmentierung - Google Patents
Carbostyrylderivate zur inhibition von hautrötungen und/oder von hautpigmentierungInfo
- Publication number
- ATE279395T1 ATE279395T1 AT98937851T AT98937851T ATE279395T1 AT E279395 T1 ATE279395 T1 AT E279395T1 AT 98937851 T AT98937851 T AT 98937851T AT 98937851 T AT98937851 T AT 98937851T AT E279395 T1 ATE279395 T1 AT E279395T1
- Authority
- AT
- Austria
- Prior art keywords
- skin
- inhibiting
- redness
- pigmentation
- carbostyryl derivatives
- Prior art date
Links
- MJXYFLJHTUSJGU-UHFFFAOYSA-N 7-amino-4-methyl-1h-quinolin-2-one Chemical class NC1=CC=C2C(C)=CC(=O)NC2=C1 MJXYFLJHTUSJGU-UHFFFAOYSA-N 0.000 title 1
- 208000012641 Pigmentation disease Diseases 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22243197 | 1997-08-19 | ||
| PCT/JP1998/003657 WO1999009011A1 (en) | 1997-08-19 | 1998-08-18 | Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE279395T1 true ATE279395T1 (de) | 2004-10-15 |
Family
ID=16782296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98937851T ATE279395T1 (de) | 1997-08-19 | 1998-08-18 | Carbostyrylderivate zur inhibition von hautrötungen und/oder von hautpigmentierung |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6133264A (de) |
| EP (1) | EP1005458B1 (de) |
| JP (1) | JPH11124366A (de) |
| KR (1) | KR100397201B1 (de) |
| CN (1) | CN1141298C (de) |
| AR (1) | AR013945A1 (de) |
| AT (1) | ATE279395T1 (de) |
| AU (1) | AU725464B2 (de) |
| BR (1) | BR9811307A (de) |
| CA (1) | CA2297439C (de) |
| DE (1) | DE69827014T2 (de) |
| DK (1) | DK1005458T3 (de) |
| EG (1) | EG24161A (de) |
| ES (1) | ES2232001T3 (de) |
| HK (1) | HK1029346A1 (de) |
| ID (1) | ID23521A (de) |
| MY (1) | MY115907A (de) |
| PT (1) | PT1005458E (de) |
| TW (1) | TW436483B (de) |
| WO (1) | WO1999009011A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020034772A1 (en) | 1999-06-29 | 2002-03-21 | Orlow Seth J. | Methods and compositions that affect melanogenesis |
| US20020114769A1 (en) * | 2000-09-14 | 2002-08-22 | Rotenberg Susan A. | Novel dequalinium analogs |
| US8563754B2 (en) | 2010-01-28 | 2013-10-22 | New York University | Compounds, compositions and methods for preventing skin darkening |
| WO2012103487A1 (en) | 2011-01-27 | 2012-08-02 | New York University | Coumarin compounds as melanogenesis modifiers and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1219587A (en) * | 1981-12-14 | 1987-03-24 | Norman P. Jensen | Hydroxybenzylaminobenzenes as anti-inflammatory agents |
| US5082847A (en) * | 1990-07-18 | 1992-01-21 | Syntex (U.S.A.) Inc. | Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility |
| EP0638571A4 (de) * | 1992-05-01 | 1995-04-12 | Kowa Co | Chinolinderivate oder deren salze und diese enthaltende heilmittel für herzerkrankungen. |
| TW448161B (en) * | 1994-07-14 | 2001-08-01 | Otsuka Pharma Co Ltd | Cyclic amide derivatives |
| ATE199552T1 (de) * | 1995-07-07 | 2001-03-15 | Pfizer | Substituierte benzolaktamverbindungen als substanz-p-antagonisten |
| CA2254756A1 (en) * | 1996-05-20 | 1997-11-27 | Mark Goulet | Antagonists of gonadotropin releasing hormone |
| WO1997044321A1 (en) * | 1996-05-20 | 1997-11-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
-
1998
- 1998-07-23 TW TW087112066A patent/TW436483B/zh not_active IP Right Cessation
- 1998-08-13 EG EG94298A patent/EG24161A/xx active
- 1998-08-17 JP JP10230407A patent/JPH11124366A/ja active Pending
- 1998-08-18 AT AT98937851T patent/ATE279395T1/de not_active IP Right Cessation
- 1998-08-18 AU AU86500/98A patent/AU725464B2/en not_active Ceased
- 1998-08-18 CA CA002297439A patent/CA2297439C/en not_active Expired - Fee Related
- 1998-08-18 MY MYPI98003752A patent/MY115907A/en unknown
- 1998-08-18 BR BR9811307-0A patent/BR9811307A/pt not_active IP Right Cessation
- 1998-08-18 DE DE69827014T patent/DE69827014T2/de not_active Expired - Fee Related
- 1998-08-18 ID IDW20000312A patent/ID23521A/id unknown
- 1998-08-18 ES ES98937851T patent/ES2232001T3/es not_active Expired - Lifetime
- 1998-08-18 CN CNB988082772A patent/CN1141298C/zh not_active Expired - Fee Related
- 1998-08-18 PT PT98937851T patent/PT1005458E/pt unknown
- 1998-08-18 EP EP98937851A patent/EP1005458B1/de not_active Expired - Lifetime
- 1998-08-18 AR ARP980104065A patent/AR013945A1/es active IP Right Grant
- 1998-08-18 WO PCT/JP1998/003657 patent/WO1999009011A1/en active IP Right Grant
- 1998-08-18 KR KR10-2000-7001705A patent/KR100397201B1/ko not_active IP Right Cessation
- 1998-08-18 US US09/485,454 patent/US6133264A/en not_active Expired - Fee Related
- 1998-08-18 DK DK98937851T patent/DK1005458T3/da active
-
2001
- 2001-01-11 HK HK01100255A patent/HK1029346A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010023086A (ko) | 2001-03-26 |
| JPH11124366A (ja) | 1999-05-11 |
| KR100397201B1 (ko) | 2003-09-13 |
| TW436483B (en) | 2001-05-28 |
| AU8650098A (en) | 1999-03-08 |
| BR9811307A (pt) | 2000-08-29 |
| MY115907A (en) | 2003-09-30 |
| EP1005458B1 (de) | 2004-10-13 |
| DK1005458T3 (da) | 2005-01-31 |
| CN1141298C (zh) | 2004-03-10 |
| DE69827014T2 (de) | 2005-03-17 |
| DE69827014D1 (de) | 2004-11-18 |
| ID23521A (id) | 2000-04-27 |
| CA2297439A1 (en) | 1999-02-25 |
| PT1005458E (pt) | 2005-01-31 |
| WO1999009011A1 (en) | 1999-02-25 |
| ES2232001T3 (es) | 2005-05-16 |
| CA2297439C (en) | 2006-12-19 |
| HK1029346A1 (en) | 2001-03-30 |
| EG24161A (en) | 2008-08-20 |
| AU725464B2 (en) | 2000-10-12 |
| EP1005458A1 (de) | 2000-06-07 |
| CN1267284A (zh) | 2000-09-20 |
| AR013945A1 (es) | 2001-01-31 |
| US6133264A (en) | 2000-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT948308E (pt) | Metodos para o tratamento de pigmentacao da pele | |
| IL133194A0 (en) | A composition and method for inhibiting photoaging of human skin | |
| GB2335147B (en) | Methods and devices for inhibiting hair growth and related skin treatments | |
| DE69838338D1 (de) | Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen | |
| HUP9904361A3 (en) | Use of isobutylgaba and its derivatives for the treatment of pain | |
| BR9508886A (pt) | Compostos e métodos para o tratamento de câncer | |
| DE69716251D1 (de) | Verwendung von oktoxyglyzerin in einer kosmetische und/oder dermatologische zusammensetzung zur behandlung von seborrhea und akne | |
| DE69836209D1 (de) | Vorbeugung und behandlunhg des hepatozellulären krebses | |
| AU4872897A (en) | Use of the inhibitors of the activity of retinoic acid for treating sensitive skins and/or the acute damage induced by UV radiation | |
| DE69841550D1 (de) | Behandlung von fibromyalgie und verwandten erkrankungen | |
| DE69729504D1 (de) | Zusammensetzung zum Hautschutz und zur Vitamineabgabe | |
| ATE279395T1 (de) | Carbostyrylderivate zur inhibition von hautrötungen und/oder von hautpigmentierung | |
| DE59607881D1 (de) | Verfahren zur hemmung sorbatinduzierter braunverfärbungen in kosmetischen mitteln und lebensmitteln | |
| GB9929497D0 (en) | Improved amino acid mixtures for the treatment and/or management of certain diseases | |
| ATE238796T1 (de) | Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten | |
| HUP0000785A3 (en) | Ointment for the treatment of burns and other skin diseases | |
| PL324929A1 (en) | Cosmetic method of treating and preventing the symptoms of skin ageing | |
| DE69629027D1 (de) | Kosmetische zubereitung zur prävention und beseitigung von hautschäden | |
| DE69930603D1 (de) | Zusammensetzung zur Wiederherstellung und Stimulierung der Hautbarrierefunktion | |
| DE69836559D1 (de) | Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung | |
| ATE288279T1 (de) | Arzneimittel zur vermeidung oder behandlung von papillomavirus-spezifischem tumor | |
| ATE224711T1 (de) | Formulierung zur behandlung und/oder vorbeugung von dementia | |
| DE69600034D1 (de) | Zusammensetzung zum Schutz der Haut und/oder zur Bekämpfung von Hautflecken und/oder Hautalterung und ihre Verwendungen | |
| ATA133393A (de) | Vorrichtung zur behandlung des rippen- und des lungenfells zur durchfuehrung der pleurodese | |
| PL336626A1 (en) | Methods of preventing and treating traumatic loss of metabolic equlibrium among human beings and animals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1005458 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |